Veracyte, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 7.57%

Veracyte, Inc. EBT Margin is 7.57% for the Trailing 12 Months (TTM) ending March 31, 2025, a -140.36% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Veracyte, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -18.76%, a 94.21% change year over year.
  • Veracyte, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -9.66%, a -52.03% change year over year.
  • Veracyte, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -20.13%, a -64.02% change year over year.
  • Veracyte, Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -55.95%, a 204.66% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin